Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,050 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies

NCT00215605

Conditions
Adenocarcinoma, Cancer, Carcinoma, +23 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

PET Study in Patients With Non-Hodgkin Lymphoma

NCT00712556

Conditions
Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations
  • Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients

NCT00741377

Conditions
Blood Protein Disorders, Bone Diseases, Cardiovascular Diseases, +15 more
Locations
  • Mayo Clinic - Arizona Cancer Clinical Research Unit Scottsdale, Arizona, United States
  • Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States
  • Dana Farber Cancer Institute Deptof DanaFarberCancerInst(2) Boston, Massachusetts, United States
  • MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (11) Houston, Texas, United States
View Trial Details

Related conditions